Mandate

Vinge has advised Visa in connection with its investment in Mynt AB

April 14, 2025 M&A

Vinge has advised Visa in connection with its investment in the Swedish fintech company Mynt AB ("Mynt"). The investment, which is part of Mynt's announced Series B funding round, underscores Visa's commitment to supporting innovative fintech solutions and improving payment experiences for businesses across Europe.

Mynt is a Swedish-founded SaaS fintech company specialising in spend management solutions, delivering services that help business owners simplify their administration and bookkeeping by offering a corporate card that integrates with customers' accounting systems via Mynt's platform. The partnership will enable Visa to better meet its clients’ needs and the underserved small and medium-sized businesses (“SMBs”) market, while enabling Mynt to address the growing demand for efficient spend management among SMBs.

Vinge was represented by Johan Larsson and Helena Liljenberg.

Read the client’s press release here.

Related

Vinge advised Precise Biometrics

Vinge has advised Precise Biometrics AB in connection with the merger with Fingerprint Cards.
March 27, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 83 million before transaction costs, with an over-allotment issue of approximately SEK 30 million.
March 26, 2026

Vinge advises Diamyd Medical in connection with directed issuances of shares and warrants of up to SEK 1,166 million

Vinge advises Diamyd Medical Aktiebolag (“Diamyd Medical”), listed on Nasdaq First North Growth Market, in connection with directed issuances of shares and warrants whereby Diamyd Medical receives gross proceeds of approximately SEK 1,166 million, if all warrants are exercised.
March 25, 2026